About ATLAB Pharma
ATLAB Pharma is a company based in Nantes (France) founded in 2008 was acquired by Telix Pharma in September 2018. ATLAB Pharma operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Nantes, France
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$7.94 M (USD), Grant
Jun 02, 2009
- Investors
-
Employee Count
Not available
-
Acquired by
Telix Pharma
(Sep 11, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ATLAB Pharma
Investors in ATLAB Pharma
ATLAB Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Telix Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Theranostic radiopharmaceuticals are developed for cancer imaging and therapy.
|
Locked | Locked | Locked |
Investor details for ATLAB Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ATLAB Pharma
Investment portfolio details for ATLAB Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ATLAB Pharma
Detailed financials for ATLAB Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Atlab Pharma Comparisons
Peer comparison for ATLAB Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ATLAB Pharma
ATLAB Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| Locked | Locked | Locked |
Small molecules are developed for cancer and skin disease treatments.
|
|
| Locked | Locked | Locked |
Cancer therapies are developed using selective pathway inhibitors.
|
Detailed competitors of ATLAB Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Atlab Pharma
Complete news archive for ATLAB Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ATLAB Pharma
ATLAB Pharma was founded in 2008 and raised its 1st funding round 1 year after it was founded.
ATLAB Pharma is headquartered in Nantes, France. It is registered at Nantes, Pays De La Loire, France.
ATLAB Pharma was founded in 2008 and is based in Nantes, France. Operations focus on the biotechnology sector, specifically radio immunotherapy for cancer. Monoclonal antibodies conjugated to radioisotopes are developed to deliver targeted radiation to tumor cells. The lead candidate, ATL101, targets prostate-specific membrane antigen using Lutetium-177 and has demonstrated safety and anti-tumor activity in Phase I and II trials for castrate-resistant prostate cancer.
ATLAB Pharma's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
ATLAB Pharma has 1 investor. Key investors include Telix Pharmaceuticals.